Summary

The global Clinical Trial Manufacturing Service market size is predicted to grow from US$ 1140 million in 2025 to US$ 1490 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.
Clinical trial manufacturing service is a service that provides customized production for drugs, medical devices and biological products in the clinical trial stage. This service usually includes the entire manufacturing process from raw material procurement, production process design, quality control to packaging and transportation. Clinical trial manufacturing service is designed to meet the special needs of clinical trials for products, such as small batches, multiple batches, and rapid response. Through a professional production team and advanced production equipment, clinical trial manufacturing service can ensure the safety and effectiveness of products while complying with relevant laws and regulations and regulatory requirements. In addition, this service can also provide flexible production solutions and make timely adjustments and optimizations according to the progress and needs of clinical trials. Clinical trial manufacturing service is of great significance to promoting the development of new drugs and improving the quality of clinical trials of medical devices and biological products, and provides strong support for the launch of new drugs and medical innovation.
United States market for Clinical Trial Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Clinical Trial Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Clinical Trial Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Clinical Trial Manufacturing Service players cover SGS, Intertek, Pharmsky, SK pharmteco, Quotient Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Clinical Trial Manufacturing Service Industry Forecast” looks at past sales and reviews total world Clinical Trial Manufacturing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Trial Manufacturing Service sales for 2025 through 2031. With Clinical Trial Manufacturing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Manufacturing Service industry.
This Insight Report provides a comprehensive analysis of the global Clinical Trial Manufacturing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial Manufacturing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Trial Manufacturing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Manufacturing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Manufacturing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Manufacturing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Phase I Clinical Trial Manufacturing Service
Phase II Clinical Trial Manufacturing Service
Phase III Clinical Trial Manufacturing Service
Segmentation by Application:
Oral Medications
Inhaled Medications
Parenteral Medications
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SGS
Intertek
Pharmsky
SK pharmteco
Quotient Sciences
UPM Pharmaceuticals
Sharp Services
PCI
NUVISAN
Vetter-Pharma
Lonza
MAC Research
Cambrex
Nanopharm
Patheon

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Clinical Trial Manufacturing Service Market Size (2020-2031)
2.1.2 Clinical Trial Manufacturing Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Clinical Trial Manufacturing Service by Country/Region (2020, 2024 & 2031)
2.2 Clinical Trial Manufacturing Service Segment by Type
2.2.1 Phase I Clinical Trial Manufacturing Service
2.2.2 Phase II Clinical Trial Manufacturing Service
2.2.3 Phase III Clinical Trial Manufacturing Service
2.3 Clinical Trial Manufacturing Service Market Size by Type
2.3.1 Clinical Trial Manufacturing Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Clinical Trial Manufacturing Service Market Size Market Share by Type (2020-2025)
2.4 Clinical Trial Manufacturing Service Segment by Application
2.4.1 Oral Medications
2.4.2 Inhaled Medications
2.4.3 Parenteral Medications
2.4.4 Others
2.5 Clinical Trial Manufacturing Service Market Size by Application
2.5.1 Clinical Trial Manufacturing Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Clinical Trial Manufacturing Service Market Size Market Share by Application (2020-2025)
3 Clinical Trial Manufacturing Service Market Size by Player
3.1 Clinical Trial Manufacturing Service Market Size Market Share by Player
3.1.1 Global Clinical Trial Manufacturing Service Revenue by Player (2020-2025)
3.1.2 Global Clinical Trial Manufacturing Service Revenue Market Share by Player (2020-2025)
3.2 Global Clinical Trial Manufacturing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Trial Manufacturing Service by Region
4.1 Clinical Trial Manufacturing Service Market Size by Region (2020-2025)
4.2 Global Clinical Trial Manufacturing Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Clinical Trial Manufacturing Service Market Size Growth (2020-2025)
4.4 APAC Clinical Trial Manufacturing Service Market Size Growth (2020-2025)
4.5 Europe Clinical Trial Manufacturing Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Clinical Trial Manufacturing Service Market Size Growth (2020-2025)
5 Americas
5.1 Americas Clinical Trial Manufacturing Service Market Size by Country (2020-2025)
5.2 Americas Clinical Trial Manufacturing Service Market Size by Type (2020-2025)
5.3 Americas Clinical Trial Manufacturing Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Trial Manufacturing Service Market Size by Region (2020-2025)
6.2 APAC Clinical Trial Manufacturing Service Market Size by Type (2020-2025)
6.3 APAC Clinical Trial Manufacturing Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Trial Manufacturing Service Market Size by Country (2020-2025)
7.2 Europe Clinical Trial Manufacturing Service Market Size by Type (2020-2025)
7.3 Europe Clinical Trial Manufacturing Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Trial Manufacturing Service by Region (2020-2025)
8.2 Middle East & Africa Clinical Trial Manufacturing Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Clinical Trial Manufacturing Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Clinical Trial Manufacturing Service Market Forecast
10.1 Global Clinical Trial Manufacturing Service Forecast by Region (2026-2031)
10.1.1 Global Clinical Trial Manufacturing Service Forecast by Region (2026-2031)
10.1.2 Americas Clinical Trial Manufacturing Service Forecast
10.1.3 APAC Clinical Trial Manufacturing Service Forecast
10.1.4 Europe Clinical Trial Manufacturing Service Forecast
10.1.5 Middle East & Africa Clinical Trial Manufacturing Service Forecast
10.2 Americas Clinical Trial Manufacturing Service Forecast by Country (2026-2031)
10.2.1 United States Market Clinical Trial Manufacturing Service Forecast
10.2.2 Canada Market Clinical Trial Manufacturing Service Forecast
10.2.3 Mexico Market Clinical Trial Manufacturing Service Forecast
10.2.4 Brazil Market Clinical Trial Manufacturing Service Forecast
10.3 APAC Clinical Trial Manufacturing Service Forecast by Region (2026-2031)
10.3.1 China Clinical Trial Manufacturing Service Market Forecast
10.3.2 Japan Market Clinical Trial Manufacturing Service Forecast
10.3.3 Korea Market Clinical Trial Manufacturing Service Forecast
10.3.4 Southeast Asia Market Clinical Trial Manufacturing Service Forecast
10.3.5 India Market Clinical Trial Manufacturing Service Forecast
10.3.6 Australia Market Clinical Trial Manufacturing Service Forecast
10.4 Europe Clinical Trial Manufacturing Service Forecast by Country (2026-2031)
10.4.1 Germany Market Clinical Trial Manufacturing Service Forecast
10.4.2 France Market Clinical Trial Manufacturing Service Forecast
10.4.3 UK Market Clinical Trial Manufacturing Service Forecast
10.4.4 Italy Market Clinical Trial Manufacturing Service Forecast
10.4.5 Russia Market Clinical Trial Manufacturing Service Forecast
10.5 Middle East & Africa Clinical Trial Manufacturing Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Clinical Trial Manufacturing Service Forecast
10.5.2 South Africa Market Clinical Trial Manufacturing Service Forecast
10.5.3 Israel Market Clinical Trial Manufacturing Service Forecast
10.5.4 Turkey Market Clinical Trial Manufacturing Service Forecast
10.6 Global Clinical Trial Manufacturing Service Forecast by Type (2026-2031)
10.7 Global Clinical Trial Manufacturing Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Clinical Trial Manufacturing Service Forecast
11 Key Players Analysis
11.1 SGS
11.1.1 SGS Company Information
11.1.2 SGS Clinical Trial Manufacturing Service Product Offered
11.1.3 SGS Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 SGS Main Business Overview
11.1.5 SGS Latest Developments
11.2 Intertek
11.2.1 Intertek Company Information
11.2.2 Intertek Clinical Trial Manufacturing Service Product Offered
11.2.3 Intertek Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Intertek Main Business Overview
11.2.5 Intertek Latest Developments
11.3 Pharmsky
11.3.1 Pharmsky Company Information
11.3.2 Pharmsky Clinical Trial Manufacturing Service Product Offered
11.3.3 Pharmsky Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pharmsky Main Business Overview
11.3.5 Pharmsky Latest Developments
11.4 SK pharmteco
11.4.1 SK pharmteco Company Information
11.4.2 SK pharmteco Clinical Trial Manufacturing Service Product Offered
11.4.3 SK pharmteco Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 SK pharmteco Main Business Overview
11.4.5 SK pharmteco Latest Developments
11.5 Quotient Sciences
11.5.1 Quotient Sciences Company Information
11.5.2 Quotient Sciences Clinical Trial Manufacturing Service Product Offered
11.5.3 Quotient Sciences Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Quotient Sciences Main Business Overview
11.5.5 Quotient Sciences Latest Developments
11.6 UPM Pharmaceuticals
11.6.1 UPM Pharmaceuticals Company Information
11.6.2 UPM Pharmaceuticals Clinical Trial Manufacturing Service Product Offered
11.6.3 UPM Pharmaceuticals Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 UPM Pharmaceuticals Main Business Overview
11.6.5 UPM Pharmaceuticals Latest Developments
11.7 Sharp Services
11.7.1 Sharp Services Company Information
11.7.2 Sharp Services Clinical Trial Manufacturing Service Product Offered
11.7.3 Sharp Services Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sharp Services Main Business Overview
11.7.5 Sharp Services Latest Developments
11.8 PCI
11.8.1 PCI Company Information
11.8.2 PCI Clinical Trial Manufacturing Service Product Offered
11.8.3 PCI Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 PCI Main Business Overview
11.8.5 PCI Latest Developments
11.9 NUVISAN
11.9.1 NUVISAN Company Information
11.9.2 NUVISAN Clinical Trial Manufacturing Service Product Offered
11.9.3 NUVISAN Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 NUVISAN Main Business Overview
11.9.5 NUVISAN Latest Developments
11.10 Vetter-Pharma
11.10.1 Vetter-Pharma Company Information
11.10.2 Vetter-Pharma Clinical Trial Manufacturing Service Product Offered
11.10.3 Vetter-Pharma Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Vetter-Pharma Main Business Overview
11.10.5 Vetter-Pharma Latest Developments
11.11 Lonza
11.11.1 Lonza Company Information
11.11.2 Lonza Clinical Trial Manufacturing Service Product Offered
11.11.3 Lonza Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Lonza Main Business Overview
11.11.5 Lonza Latest Developments
11.12 MAC Research
11.12.1 MAC Research Company Information
11.12.2 MAC Research Clinical Trial Manufacturing Service Product Offered
11.12.3 MAC Research Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 MAC Research Main Business Overview
11.12.5 MAC Research Latest Developments
11.13 Cambrex
11.13.1 Cambrex Company Information
11.13.2 Cambrex Clinical Trial Manufacturing Service Product Offered
11.13.3 Cambrex Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cambrex Main Business Overview
11.13.5 Cambrex Latest Developments
11.14 Nanopharm
11.14.1 Nanopharm Company Information
11.14.2 Nanopharm Clinical Trial Manufacturing Service Product Offered
11.14.3 Nanopharm Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Nanopharm Main Business Overview
11.14.5 Nanopharm Latest Developments
11.15 Patheon
11.15.1 Patheon Company Information
11.15.2 Patheon Clinical Trial Manufacturing Service Product Offered
11.15.3 Patheon Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Patheon Main Business Overview
11.15.5 Patheon Latest Developments
12 Research Findings and Conclusion